Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.

Investment adviser Innovatus Capital Partners has agreed to provide up to $42m in funding for Personal Genome Diagnostics (PGDx), a US-based oncology diagnostics developer spun out of Johns Hopkins University. PGDx is developing in vitro genomic liquid and tissue-based biopsy products that will be able to help physicians fine tune treatments for cancer patients based…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.